In the morning of March 30, Wang Bin, director of the comprehensive sales expansion department of Jiejing Group, organized personnel from quality dept., project dept., research and development dept., and production technology to visit Qingdao Marine Biomedical Research Institute. Guan Lushi, deputy general manager of the institute, and Dr. Li Quancai, assistant dean, received our company's delegation.

Dr. Li Quancai first led a tour of the product exhibition area and the ocean sugar engineering drug research and development room, introducing the products that have been launched and the current research projects. At the symposium, Guan provided guidance and suggestions on topics such as marine bioscience research, marine drug development, and sustainable development of the blue ocean economy. Both sides conducted in-depth discussions on the application research of seaweed active substances in marine functional foods, health foods and raw materials, and marine biomedicine.

 

In order to fully leverage and integrate our respective advantages, support and lead technological innovation in the marine biopharmaceutical industry, and promote the rapid development of the marine biopharmaceutical industry, both parties have reached cooperation intentions in the maturation and development of marine scientific and technological achievements and technology transfer and transformation.